Revolutionizing Next-Generation Sequencing
About This Event:
During this conference the following topics will be covered:
- Long reads & genome structure
- Spatial technologies
- Population scale and clinical sequencing
- Technology trends
March 11-12, 2021
Samuel A. Inverso, Ph.D.
Vice President, Global Partnerships
Sam has formed and run cross-functional teams of molecular biologists, software engineers, and bioinformaticians in large scale multi-year projects. He has overseen more than $30 million in funding from pharma, universities, and the federal government. Sam excels at building and communicating strategic frameworks that bridge science and business objectives. At ReadCoor, he is engaged in corporate and business development. He manages collaborations with pharmaceutical and research institutes, including a Bill & Melinda Gates Foundation award and partnership with WAVE Life Sciences.
Prior to being a founding team member of ReadCoor, Sam was a Staff Engineer at the Wyss Institute for Biologically Inspired Engineering at Harvard University. At the Wyss, he contributed to analysis algorithms and bioinformatics for Fluorescent in situ Sequencing and is a co-author on the seminal 2014 Science paper. In addition, he was co-PI (with George Church) on a multi-million-dollar multi-year IARPA MICrONS project to use FISSEQ to map the neural circuits of a mouse brain at the synaptic level. The role included managing a large team of staff, postdocs, graduate students, and research assistants in interdisciplinary fields from molecular biology and engineering in a large consortium that included MIT, CSHL, and Columbia.
Sam received his Bachelor of Science and Master of Science in Computer Science from the Rochester Institute of Technology. He has a Ph.D. in Neuroscience from the Australian National University and Postdoctoral training in Alzheimer’s Disease at the Institut Pasteur.
Learn more about this event: